Previous Article | Next Article ![]()
Infection and Immunity, March 2002, p. 1599-1603, Vol. 70, No. 3
0019-9567/02/$04.00+0 DOI: 10.1128/IAI.70.3.1599-1603.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Program in Vector-Borne Diseases, Department of Veterinary Microbiology and Pathology, Washington State University, Pullman, Washington 99164-7040,1 Animal Disease Research Unit, Agricultural Research Service, U.S. Department of Agriculture, Pullman, Washington 99164-7030,2 Agricultural Research Service, U.S. Department of Agriculture, Moscow, Idaho 83844-22013
Received 28 August 2001/ Returned for modification 17 October 2001/ Accepted 3 December 2001
| ABSTRACT |
|---|
|
|
|---|
| TEXT |
|---|
|
|
|---|
Babesial merozoites, like other apicomplexan parasites, use a combination of cell surface and apical complex molecules to bind and invade host cells (2, 4, 29). In B. bovis, merozoite surface antigen 1 (MSA-1) and rhoptry-associated protein 1 (RAP-1) are postulated to be involved in the merozoite invasion of erythrocytes. MSA-1 is a 42-kDa glycoprotein that belongs to the family of variable merozoite surface antigens (VMSA) and is uniformly distributed on the surface of B. bovis merozoites (8, 9, 16). MSA-1 is encoded by a single gene, and antibodies against either native or recombinant MSA-1 neutralize merozoite infection in vitro, suggesting a role in the early steps of erythrocyte invasion (10, 11, 30). RAP-1 of B. bovis is a 60-kDa protein localized to the apical surface and within the rhoptries of merozoites (8, 26, 33). RAP-1 is encoded by two identical, tandemly arranged rap-1a genes and is highly conserved among diverse isolates (1, 31-33). Studies using its orthologue in B. bigemina, a 58-kDa RAP-1, show that monoclonal antibodies (MAbs) against RAP-1 are able to inhibit multiplication in vitro (5, 6). Consistent with a role in invasion, calves immunized with native RAP-1 or a recombinant fusion protein develop a significantly reduced mean peak parasitemia upon merozoite challenge (20, 34).
To obtain sporozoites for the examination of msa-1 and rap-1 expression, adult B. microplus ticks were allowed to feed on a splenectomized calf by using skin patches (12). A Babesia-free colony of B. microplus ticks (La Minita strain) was used in all the experiments. Adult female ticks start engorgement approximately 21 days after being placed on the calf (22). Calves were inoculated with 5 ml of the Mexico strain of B. bovis at 13 days postattachment so that parasitemia, determined by microscopic examination of Giemsa-stained blood smears, was maximal during the final stages of female tick engorgement. Engorged ticks were washed and placed in individual vials during ovoposition (13). To obtain a high percentage of infected ticks, only those females replete during the period of highest parasitemia were used. Infection of female ticks was determined on day 10 of ovoposition by the hemolymph test (28), and only eggs from infected females with more than 10 kinetes per hemolymph sample were used. Eggs laid during the first 120 h postengorgement were discarded, and the rest of the eggs were incubated at 27°C and 92% relative humidity for 3 weeks (17). Once the larvae hatched and their cuticles hardened, they were kept at 14°C and 92% relative humidity for an additional 21 days (3). To stimulate the development of B. bovis sporozoites, infected larvae were fed on an uninfected calf for 60 h using skin patches (R. J. Dalgliesh and N. P. Stewart, Letter, Aust. Vet. J. 52:543, 1976). After this period, larvae were removed and incubated at 37°C for an additional 12 h. Uninfected larvae were obtained by using the same procedure, with ticks from the same colony, except that the adult ticks were fed on an uninfected calf. Temperature and humidity conditions were the same for uninfected adult ticks, eggs, and larvae as those used for the infected ticks.
B. bovis migration to salivary glands occurs only after larval feeding commences (23). Inside the salivary gland cells, B. bovis kinetes increase in size and mature into round sporonts from which thousands of sporozoites develop during larval engorgement 3 to 4 days after initial attachment (27). Since maximum sporozoite development occurs at 72 h after larval attachment, infected larvae were examined during this period. To determine if msa-1 and rap-1 transcripts are present in B. bovis stages in fed larvae, transcriptional analysis was carried out using a reverse transcriptase PCR (RT-PCR) on larval extracts. Infected larvae were homogenized in a mortar, and total RNA was extracted using TRIzol Reagent (Gibco BRL). The msa-1 primers (forward and reverse primers for msa-1 were 5'-GCTACGTTTGCTCTTTTCATT and 5'-TTGCAATTCCTTTTCTAATGC, respectively) were predicted to amplify a fragment from nucleotides 4 to 714, and the rap-1 primers (forward and reverse primers for rap-1 were 5'-CTCGCTCCAGCTGAAGTGGTA and 5'-GGAGCTTCAACGTACGAGGTC, respectively) were designed to amplify a fragment from nucleotides 91 to 890. The resulting amplicons from infected larvae had the expected sizes of 711 bp (msa-1) and 800 bp (rap-1) (Fig. 1). The cDNA sequences obtained were 100% identical to the published sequences of both genes (msa-1 accession number, M77192; rap-1 accession number, M38218). Amplicons of similar size to the msa-1 and rap-1 fragments were identified in cDNA from merozoite samples obtained from the in vitro-cultured Mo7 clone, used as a positive control. No amplification was observed when RNA from uninfected larvae was used or when RT was omitted, confirming specificity and purity of RNA (Fig. 1). Presence of cDNA in uninfected larval samples was confirmed by amplification of a 400-bp fragment of Bm86, a B. microplus gene (25).
|
|
MSA-1-specific MAb 23/10.36.18 recognized both sporozoites bound to erythrocytes (Fig. 3A) and early intra-erythrocytic stages (Fig. 3B). MAb BABB75A4 against RAP-1 also bound to sporozoites attached to the erythrocyte membrane (Fig. 3D) and to early intra-erythrocytic stages (Fig. 3E). Both MAbs reacted with cultured merozoites used as positive controls (Fig. 3C and 3F) but did not bind erythrocytes cultured alone or with extracts from uninfected larvae (data not shown). Neither sporozoites (Fig. 3G) nor merozoites (Fig. 3H) were bound by negative-control MAb ANA22B1. The detection of MSA-1 and RAP-1 proteins both within the infected larvae at 72 h postattachment and in sporozoites attached to erythrocytes in vitro confirms that both of these molecules are expressed in sporozoites.
|
At 5 h, cultures of sporozoites incubated with either of two bovine antisera against MSA-1 showed a significantly lower number of sporozoites attached to the erythrocyte membrane when compared to sporozoites incubated with medium alone or with an unrelated bovine antiserum against ovalbumin (Fig. 4A). Rabbit antisera against RAP-1 also blocked attachment, as indicated by a significantly lower number of sporozoites attached to erythrocytes when compared to medium alone or to control rabbit antiserum against recombinant A. marginale MSP-2 (Fig. 4B). When examined at 48 h, antisera against MSA-1 and RAP-1 still showed significant inhibition of sporozoite attachment compared to the control groups (data not shown), and the percentage of inhibition was similar to that of cultures incubated for 5 h. The level of inhibition of sporozoite attachment at 5 h (59 to 68% in this study) is similar to previous results for MSA-1 antibody inhibition of merozoite invasion (71%) (11). Previously, in vitro inhibition of merozoite multiplication by RAP-1 antibodies has been demonstrated only in B. bigemina using MAbs. A MAb against a surface exposed region of RAP-1 inhibited 62% of merozoite multiplication (5). In the present experiment with B. bovis, the percentage inhibition of sporozoite attachment to erythrocytes at 5 h was up to 61% with the anti-RAP-1 sera, comparable to the previous results with B. bigemina merozoites. This is the first report of inhibition of B. bovis attachment or invasion by any stage using RAP-1 antibodies. Since we tested only sporozoite viability prior to incubation with antibodies, we cannot rule out an effect of antibody on sporozoite survival that subsequently resulted in decreased binding compared with actual neutralization of a receptor-ligand interaction. Nonetheless, these results demonstrate that antibodies against MSA-1 and RAP-1 can inhibit babesial infection initiated by sporozoites, as well as subsequent cycles of merozoite invasion (5, 11).
|
| ACKNOWLEDGMENTS |
|---|
The technical assistance of Ralph Horn, Beverly Hunter, and Carla Robertson is greatly appreciated, as is the administrative support of Don Knowles.
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
| 1. | Brown, W. C., T. F. McElwain, B. J. Ruef, C. E. Suarez, V. Shkap, C. G. Chitko-McKown, W. Tuo, A. C. Rice-Ficht, and G. H. Palmer. 1996. Babesia bovis rhoptry-associated protein 1 is immunodominant for T helper cells of immune cattle and contains T-cell epitopes conserved among geographically distant B. bovis strains. Infect. Immun. 64:3341-3350. |
| 2. | Chitnis, C. E., and M. J. Blackman. 2000. Host cell invasion by malaria parasites. Parasitol. Today 16:411-415.[CrossRef][Medline] |
| 3. | Dalgliesh, R. J., and N. P. Stewart. 1982. Some effects of time, temperature and feeding on infection rates with Babesia bovis and Babesia bigemina in Boophilus microplus larvae. Int J. Parasitol. 12:323-326.[CrossRef][Medline] |
| 4. | Dubremetz, J. F., N. Garcia-Reguet, V. Conseil, and M. N. Fourmaux. 1998. Apical organelles and host-cell invasion by Apicomplexa. Int. J. Parasitol. 28:1007-1013.[CrossRef][Medline] |
| 5. | Figueroa, J. V., and G. M. Buening. 1991. In vitro inhibition of multiplication of Babesia bigemina by using monoclonal antibodies. J. Clin. Microbiol. 29:997-1003. |
| 6. | Figueroa, J. V., G. M. Buening, D. A. Kinden, and T. J. Green. 1990. Identification of common surface antigens among Babesia bigemina isolates by using monoclonal antibodies. Parasitology 100(Pt. 2):161-175. |
| 7. | Friedhoff, K. T. 1988. Transmission of Babesia, p. 23-52. In M. Ristic (ed.), Babesiosis of domestic animals and man. CRC Press, Boca Raton. Fla. |
| 8. | Goff, W. L., W. C. Davis, G. H. Palmer, T. F. McElwain, W. C. Johnson, J. F. Bailey, and T. C. McGuire. 1988. Identification of Babesia bovis merozoite surface antigens by using immune bovine sera and monoclonal antibodies. Infect. Immun. 56:2363-2368. |
| 9. | Hines, S. A., T. F. McElwain, G. M. Buening, and G. H. Palmer. 1989. Molecular characterization of Babesia bovis merozoite surface proteins bearing epitopes immunodominant in protected cattle. Mol. Biochem. Parasitol. 37:1-9.[CrossRef][Medline] |
| 10. | Hines, S. A., G. H. Palmer, D. P. Jasmer, W. L. Goff, and T. F. McElwain. 1995. Immunization of cattle with recombinant Babesia bovis merozoite surface antigen-1. Infect. Immun. 63:349-352.[Abstract] |
| 11. | Hines, S. A., G. H. Palmer, D. P. Jasmer, T. C. McGuire, and T. F. McElwain. 1992. Neutralization-sensitive merozoite surface antigens of Babesia bovis encoded by members of a polymorphic gene family. Mol. Biochem. Parasitol. 55:85-94.[CrossRef][Medline] |
| 12. | Hodgson, J. L. 1991. Ph.D. thesis. Washington State University, Pullman. |
| 13. | Hodgson, J. L., D. Stiller, D. P. Jasmer, G. M. Buening, G. G. Wagner, and T. C. McGuire. 1992. Babesia bigemina: quantitation of infection in nymphal and adult Boophilus microplus using a DNA probe. Exp. Parasitol. 74:117-126.[CrossRef][Medline] |
| 14. | Hoyte, H. M. D. 1961. Initial development of infections with Babesia bigemina. J. Protozool. 8:462-466. |
| 15. | Hoyte, M. H. D. 1965. Further observations on the initial development of infections with Babesia bigemina. J. Protozool. 12:83-85.[Medline] |
| 16. | Jasmer, D. P., D. W. Reduker, S. A. Hines, L. E. Perryman, and T. C. McGuire. 1992. Surface epitope localization and gene structure of a Babesia bovis 44-kilodalton variable merozoite surface antigen. Mol. Biochem. Parasitol. 55:75-83.[CrossRef][Medline] |
| 17. | Mahoney, D. F., and G. B. Mirre. 1977. The selection of larvae of Boophilus microplus infected with Babesia bovis (syn B argentina). Res. Vet. Sci. 23:126-127.[Medline] |
| 18. | Mahoney, D. F., I. G. Wright, and P. J. Ketterer. 1973. Babesia argentina: the infectivity and immunogenicity of irradiated blood parasites for splenectomized calves. Int J. Parasitol. 3:209-317.[CrossRef][Medline] |
| 19. | McElwain, T. F., L. E. Perryman, W. C. Davis, and T. C. McGuire. 1987. Antibodies define multiple proteins with epitopes exposed on the surface of live Babesia bigemina merozoites. J. Immunol. 138:2298-2304.[Abstract] |
| 20. | McElwain, T. F., L. E. Perryman, A. J. Musoke, and T. C. McGuire. 1991. Molecular characterization and immunogenicity of neutralization-sensitive Babesia bigemina merozoite surface proteins. Mol. Biochem. Parasitol. 47:213-222.[CrossRef][Medline] |
| 21. | McGuire, T. C., G. H. Palmer, W. L. Goff, M. I. Johnson, and W. C. Davis. 1984. Common and isolate-restricted antigens of Anaplasma marginale detected with monoclonal antibodies. Infect. Immun. 45:697-700. |
| 22. | Nuñez, J. L., M. E. Muñoz-Cobeñas, and H. L. Moltedo. 1985. Boophilus microplus, the common cattle tick. Springer-Verlag, Berlin, Germany. |
| 23. | Potgieter, F. T., and H. J. Els. 1976. Light and electron microscopic observations on the development of small merozoites of Babesia bovis in Boophilus microplus larvae. Onderstepoort J. Vet. Res. 43:123-128.[Medline] |
| 24. | Purnell, R. E. 1981. Babesiosis in various hosts, p. 25-63. In M. Ristic, and J. P. Kreier (ed.), Babesiosis. Academic Press, New York, N.Y. |
| 25. | Rand, K. N., T. Moore, A. Sriskantha, K. Spring, R. Tellam, P. Willadsen, and G. S. Cobon. 1989. Cloning and expression of a protective antigen from the cattle tick Boophilus microplus. Proc. Natl. Acad. Sci. USA 86:9657-9661. |
| 26. | Reduker, D. W., D. P. Jasmer, W. L. Goff, L. E. Perryman, W. C. Davis, and T. C. McGuire. 1989. A recombinant surface protein of Babesia bovis elicits bovine antibodies that react with live merozoites. Mol. Biochem. Parasitol. 35:239-247.[CrossRef][Medline] |
| 27. | Riek, R. F. 1966. The life cycle of Babesia argentina (lignieres, 1903) (Sporozoa: Piroplasmidea) in the tick vector Boophilus microplus (Canestrini). Aust. J. Agric. Res. 17:247-254.[CrossRef] |
| 28. | Riek, R. F. 1964. The life cycle of Babesia bigemina (Smith and Kilborne, 1893) in the tick vector Boophilus microplus (Canestrini). Aust. J. Agric. Res. 15:802-821. |
| 29. | Sam-Yellowe, T. Y. 1996. Rhoptry organelles of Apicomplexa: Their role in host cell invasion and intracellular survival. Parasitol. Today 12:308-316.[CrossRef][Medline] |
| 30. | Suarez, C. E., M. Florin-Christensen, S. A. Hines, G. H. Palmer, W. C. Brown, and T. F. McElwain. 2000. Characterization of allelic variation in the Babesia bovis merozoite surface antigen 1 (MSA-1) locus and identification of a cross-reactive inhibition-sensitive MSA-1 epitope. Infect. Immun. 68:6865-6870. |
| 31. | Suarez, C. E., T. F. McElwain, I. Echaide, S. Torioni de Echaide, and G. H. Palmer. 1994. Interstrain conservation of babesial RAP-1 surface-exposed B-cell epitopes despite rap-1 genomic polymorphism. Infect. Immun. 62:3576-3579. |
| 32. | Suarez, C. E., G. H. Palmer, I. Hotzel, and T. F. McElwain. 1998. Structure, sequence, and transcriptional analysis of the Babesia bovis rap-1 multigene locus. Mol. Biochem Parasitol. 93:215-224.[CrossRef][Medline] |
| 33. | Suarez, C. E., G. H. Palmer, D. P. Jasmer, S. A. Hines, L. E. Perryman, and T. F. McElwain. 1991. Characterization of the gene encoding a 60-kilodalton Babesia bovis merozoite protein with conserved and surface exposed epitopes. Mol. Biochem Parasitol. 46:45-52.[CrossRef][Medline] |
| 34. | Wright, I. G., R. Casu, M. A. Commins, B. P. Dalrymple, K. R. Gale, B. V. Goodger, P. W. Riddles, D. J. Waltisbuhl, I. Abetz, D. A. Berrie, et al. 1992. The development of a recombinant Babesia vaccine. Vet. Parasitol. 44:3-13.[CrossRef][Medline] |
| 35. | Wright, I. G., and B. V. Goodger. 1988. Pathogenesis of Babesiosis, p. 100-118. In M. Ristic (ed.), Babesiosis of domestic animals and man. CRC Press, Boca Raton, Fla. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|